首页 | 本学科首页   官方微博 | 高级检索  
检索        

沉默LncRNA OIP5-AS1通过上调miR-34c-5p表达增加A549R细胞放射敏感性
引用本文:毛恺,丁肖华,武莉萍,毛宇径,张立国,李军,陆江.沉默LncRNA OIP5-AS1通过上调miR-34c-5p表达增加A549R细胞放射敏感性[J].中华放射肿瘤学杂志,2010,29(1):57-60.
作者姓名:毛恺  丁肖华  武莉萍  毛宇径  张立国  李军  陆江
作者单位:新乡市中心医院胸瘤二科 453000
新乡医学院三全学院检验与影像学院 453003
新乡市中心医院胸放疗科 453000
郑州大学第一附属医院 450000
摘    要:目的 探讨LncRNA OIP5-AS1对非小细胞肺癌放射抗拒细胞A549R的放射敏感性影响及作用机制。方法 X射线6Gy照射5次A549细胞建立放射抗拒细胞A549R。qRT-PCR检测A549、A549R细胞OIP5-AS1和miR-34c-5p表达水平。转染OIP5-AS1抑制剂或miR-34c-5p模拟物至A549R细胞,OIP5-AS1过表达质粒至A549细胞。流式细胞仪检测细胞凋亡,克隆形成实验检测细胞放射敏感性,蛋白印记检测p-Chk2和p-ATM蛋白表达水平。双荧光素酶实验验证OIP5-AS1与miR-34c-5p之间关系。结果 与A549细胞比,A549R细胞中OIP5-AS1表达上调(1.97±0.11︰1.01±0.05,P<0.05),miR-34c-5p表达下调(0.43±0.02︰1.02±0.06,P<0.05)。沉默OIP5-AS1+6Gy组A549R细胞中p-Chk2和p-ATM蛋白水平低于沉默对照+6Gy组(0.43±0.03︰1.39±0.15和0.51±0.05︰1.21±0.11,P<0.05),但凋亡率增加(13.29±1.25)%︰(28.47±2.31)%,P<0.05]。过表达OIP5-AS1+6Gy组A549细胞中p-Chk2和p-ATM蛋白水平高于过表达对照+6Gy组(1.23±0.13︰0.75±0.06和1.08±0.11︰0.59±0.04,P<0.05)。抑制miR-34c-5p表达逆转了沉默OIP5-AS1对A549R细胞存活分数影响,增敏比为1.42。OIP5-AS1负调控miR-34c-5p表达。结论 沉默OIP5-AS1通过上调miR-34c-5p表达增强A549R细胞放射敏感性,为放疗提供潜在的靶点。

关 键 词:A549细胞系  A549R细胞系  OIP5-AS1基因  miR-34c-5p基因  放射敏感性  
收稿时间:2019-06-18

Silencing LncRNA OIP5-AS1 increases radiosensitivity of non-small cell lung cancer A549 cell line by up-regulating miR-34c-5p expression
Mao Kai,Ding Xiaohua,Wu Liping,Mao Yujing,Zhang Liguo,Li Jun,Lu Jiang.Silencing LncRNA OIP5-AS1 increases radiosensitivity of non-small cell lung cancer A549 cell line by up-regulating miR-34c-5p expression[J].Chinese Journal of Radiation Oncology,2010,29(1):57-60.
Authors:Mao Kai  Ding Xiaohua  Wu Liping  Mao Yujing  Zhang Liguo  Li Jun  Lu Jiang
Institution:Department of Thoracic Oncology
Department of Radiotherapy, Xinxiang Central Hospital, Xinxiang 453000 China
Sanquan Medical College, College of Inspection and Imaging, Xinxiang 453003, China
First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
Abstract:Objective To investigate the effect of LncRNA OIP5-AS1 on radiosensitivity of non-small cell lung cancer (NSCLC) cells and its mechanism. Methods The radiation-resistant cell A549R was established by using A549 cells irradiated by X-ray 6Gy in 5 fractions. The expression levels of OIP5-AS1 and miR-34c-5p in A549 and A549R cells were detected by qRT-PCR. OIP5-AS1 inhibitor or miR-34c-5p mimetic was transfected into A549R cells, or OIP5-AS1 overexpression plasmid was transfected into A549 cells. Cell apoptosis was detected by flow cytometry. Cell radiosensitivity was analyzed by colony formation assay. The expression levels of p-Chk2 and p-ATM proteins were measured by Western blot. Dual luciferase assay was adopted to verify the relationship between OIP5-AS1 and miR-34c-5p. Results Compared with A549 cells, the expression of OIP5-AS1 was significantly up-regulated in A549R cells (1.97±0.11 vs.1.01±0.05,P<0.05), whereas the expression of miR-34c-5p was remarkably down-regulated (0.43±0.02 vs.1.02±0.06,P<0.05). The expression levels of p-Chk2 and p-ATM proteins in A549R cells in the silencing OIP5-AS1+6Gy group were significantly lower (0.43±0.03 vs.1.39±0.15,0.51±0.0 5 vs.1.21± 0.11,both P<0.05), whereas the apoptotic rate was significantly higher than those in the silencing control+6Gy group (13.29±1.25)% vs. (28.47±2.31)%,P<0.05)]. The expression levels of p-Chk2 and p-ATM proteins in A549 cells in overexpressing OIP5-AS1+6Gy group were significantly higher than those in overexpression control+6Gy group (1.23±0.13 vs.0.75±0.06,1.08±0.11 vs.0.59±0.04,both P<0.05). Inhibiting miR-34c-5p expression reversed the effect of silencing OIP5-AS1 on survival fraction of A549R cells (SER=1.42). OIP5-AS1 negatively regulated the expression of miR-34c-5p. Conclusion Silencing OIP5-AS1 enhances the radiosensitivity of radiation-resistant A549 cells by up-regulating the expression of miR-34c-5p, providing a potential target for radiotherapy of NSCLC cells.
Keywords:A549 cell line  A549R cell line  OIP5-AS1 gene  miR-34c-5p gene  radiosensitivity  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号